Status:
COMPLETED
QFR-based Virtual PCI Versus Angio-guided PCI
Lead Sponsor:
University Hospital of Ferrara
Conditions:
Percutaneous Coronary Intervention
Coronary Physiology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A significant portion of patients continue to experience both adverse events and symptoms after angiographically successful PCI. Beyond different underlying mechanisms non-related to epicardial diseas...
Detailed Description
Post-percutaneous coronary intervention (PCI) physiology The results of functional assessment performed after percutaneous coronary intervention (PCI) taught us that a "successful" angiography-guided ...
Eligibility Criteria
Inclusion
- Indication to PCI for either acute or chronic coronary syndrome
- Signed informed consent
Exclusion
- Planned surgical revascularization
- Prior Coronary Artery Bypass Graft (CABG) Surgery
- Culprit lesion of STEMI or NSTEMI
- Clinical or angiographic features limiting QFR computation:
- Left main or ostial right coronary artery
- Atrial fibrillation
- Ongoing ventricular arrhythmias
- Significant and persistent tachycardia
- Revascularization of a chronic total occlusion
- Non-cardiovascular co-morbidity reducing life expectancy to \< 1 year
- Any factor precluding 1-year follow-up
Key Trial Info
Start Date :
February 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04664140
Start Date
February 20 2021
End Date
May 9 2023
Last Update
May 10 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Ferrara
Cona, Ferrara, Italy, 44124
2
University Hospital Federico II
Napoli, Italy
3
Azienda Ospedaliera Santa Maria
Reggio Emilia, Italy